ReviewActa pharmaceutica Sinica. B2022

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis.

Jincheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.